Ravi Tiku’s Perspective: Decoding Today’s Headlines
Always In Pursuit Of Excellence!
Eli Lilly Stock Joins the $1 Trillion Club as LLY Hits New All-Time Highs Eli Lilly became the first U.S. health care company to reach a $1 trillion market value on November 21, 2025. …
File: A patient gets laser treatment for diabetic retinopathy (AFP via Getty) Key Findings From the Research 1. Risk of Optic Nerve Disorders Important: There is currently no treatment for NAION. 2. Link to …
Eli Lilly Says FDA Approves Zepbound for Obstructive Sleep Apnea in Adults With Obesity – WSJ On December 20, 2024, the U.S. Food and Drug Administration (FDA) approved Zepbound® (tirzepatide) as the first and …
Eli Lilly is making tirzepatide, branded as Zepbound for weight loss, available in vials for patients who pay out-of-pocket. -Eli Lilly Zepbound by Eli Lilly: New Weight Loss Solution at Half the Price Hits …
Forget Mounjaro: Eli Lilly’s Next Big Blockbuster Has Arrived | The Motley Fool Eli Lilly has just introduced its next major blockbuster drug, Zepbound, and it’s making waves in the pharmaceutical industry. On Sunday, …
A patient with Sleep-Apnea is getting the help in respiration with the help of C-PAP machine-Image-Unsplash Based on results from trials in people with sleep apnea, the company said it plans to submit the …
FDA approves Eli Lilly’s tirzepatide for weight loss | Fox Business The FDA has granted approval for Eli Lilly’s type 2 diabetes drug, tirzepatide, for use in chronic weight management. This approval formalizes the …